Skip to content
Screener

Onto Innovation ONTO Business Segments — Litigation Expenses3

Similar metrics at other companies

Napco Security Technologies logo
NSSCSingle Reportable — Litigation Settlement Expense
$16M
Alumis Inc. logo
ALMSSingle Reportable — Operating Expenses
$100.15M-15.8%
Immunome logo
IMNMSingle Reportable — Operating Expenses
-$59.33M-24.7%
LQD
LQDASingle Reportable — Program Expenses
$21.66M+64.4%
Theravance Biopharma logo
TBPHSingle Reportable — Operating Expenses
$27.18M-8.9%
Dogwood Therapeutics logo
DWTXSingle Reportable — Operating Expenses
$5.08M+14.6%

Other financials

Income statement

See full
Revenue$343.1M+35.3%
Gross profit$183.3M+50.1%
Operating income$63.6M+97.1%
Net income$60.1M+75.8%
EPS (diluted)$1.21+75.4%

Balance sheet

See full
Cash & equivalents$1.3B+476%
Total debt$17.5M+15.3%
Total equity$1.9B-2.1%
Total assets$3.7B+72.8%

Cash flow

See full
Operating cash flow$61.5M+6.2%
CapEx$3.7M-73.4%
Free cash flow$57.9M+31.0%

Valuation

See full
Market cap$13.73B+212%
P/E84.6×+58.6×
P/S12.3×+8.0×

Profitability

See full
Gross margin50.4%-1.2pp
Operating margin12%-6.4pp
Net margin14.5%-1.8pp
FCF margin22.5%-0.5pp

Returns & leverage

See full
Return on equity8.3%-0.6pp
Debt / equity0.0×
Current ratio9.7×+0.1×

Where this comes from

Reported directly by Onto Innovation in its filing.

Tagged under the XBRL concept onto:LitigationExpenses3.

The source filing: Onto Innovation’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:04 PM EST
Fiscal year
FY2025
Accession
0001193125-26-066937
Line itemYear Ended / January 3,2026Year Ended / December 28,2024Year Ended / December 30,2023
Other segment items:
Restructuring and other (4)63,38923,07710,599
Merger and acquisitions related (4)19,6017,6532,607
Litigation (4)2711,337
Amortization39,40949,43754,823
Operating income132,927187,103116,078
Interest income, net34,97133,48920,356
Other expense, net(4,996)(145)(3,852)

Item 16. Form 10-K Summary.

FAQ

What is Onto Innovation's business segments — litigation expenses3?
Onto Innovation (ONTO) reported business segments — litigation expenses3 of $0 in Q4 2025.
How has Onto Innovation's business segments — litigation expenses3 changed year-over-year?
Onto Innovation's business segments — litigation expenses3 decreased by 100.0% year-over-year, from $6.75K to $0.
What is the long-term trend for Onto Innovation's business segments — litigation expenses3?
Over 3 years (2022 to 2025), Onto Innovation's business segments — litigation expenses3 has grown at a -100.0% compound annual growth rate (CAGR), from $3.94M to $0.
What does business segments — litigation expenses3 mean?
Represents legal costs and settlements associated with ongoing or resolved disputes. This metric is used to track the financial impact of legal risks and potential liabilities on the company's bottom line.

Ask your AI about Onto Innovation's business segments — litigation expenses3.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude